SEARCH

SEARCH BY CITATION

References

  • 1
    Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, Walter E, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10: 6976.
  • 2
    Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969974.
  • 3
    Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273281.
  • 4
    Koretz FL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993; 119: 110115.
  • 5
    Mattson L, Sonnerborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver 1993; 13: 274278.
  • 6
    Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural history of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240243.
  • 7
    Yano M, Yatsuhasi H, Inoue O, Inokuchi K, Koga Ml. Epidemiology and long-term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34 (suppl): S13S16.
  • 8
    Roberts JM, Searle JW, Cooksley WGE. Histological patterns of prolonged hepatitis C virus infection. Gastroenterol Jpn 1993; 28: 901905.
  • 9
    Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 14631466.
  • 10
    Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepato-cellular carcinoma in Japan. Cancer Res 1987; 47: 49674972.
  • 11
    Nishioka K, Watanabe J, Furuta S, Tanaka E, Lino S, Suzuki H, Tsuji T, et al. A high prevalence of the antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429433.
  • 12
    Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawati H, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 28422847.
  • 13
    Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, et al. Prevalence of antibody to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 10041006.
  • 14
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardo N, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 10061008.
  • 15
    Nomura A, Stemmermann GN, Chyou P-H, Tabor E. Hepatitis B and C serologies among Japanese Americans with hepatocellular carcinoma. J Infect Dis 1996; 173: 14741476.
  • 16
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671675.
  • 17
    Crowe J, Doyle C, Fielding JF, Holloway H, Keegan M, Kelleher D, Kelly P, et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [Abstract]. Gastroenterology 1995; 108: 1054A.
  • 18
    Power JP, Lawlor E, Davidson F, Yap L, Kenny-Walsh E, Whelton MJ, Walsh TJ. Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin [Letter]. Lancet 1994; 344: 11661167.
  • 19
    Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991; 13: 323327.
  • 20
    Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Garcia-Pont P, Greenlee HB, Dietz AA, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis: a Veterans Administration cooperative study. Gastroenterology 1977; 72: 111121.
  • 21
    Seeff LB, Wright EC, Zimmerman HJ, Hoofnagle JH, Dietz AA, Felsher BF, Garcia-Pont PH, et al. Posttransfusion hepatitis, 1973–1975: a Veterans Administration Cooperative Study. In: VyasGN, CohenSN, SchmidR, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. Philadelphia: Franklin Institute, 1978: 371381.
  • 22
    Alter HJ, Purcell RH, Feinstone SM, Holland PV, Morrow AG. Non-A, non-B hepatitis: a review and interim report of an ongoing prospective study. In: VyasGN, CohenSN, SchmidR, eds. Viral hepatitis: A Contemporary Assessment of Etiology Epidemiology, Pathogenesis and Prevention. Philadelphia: Franklin Institute, 1978: 359369.
  • 23
    Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, et al. Serum alanine aminotransferase of donors in relation to risk of non-A, non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. N Engl J Med 1981: 304: 989994.
  • 24
    Knodell RG, Conrad ME, Ginsberg AL, Bell CJ, Flannery EP. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1976; 1: 557561.
  • 25
    Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 19061911.
  • 26
    Seeff LB, the NHLBI Study Group. Mortality and morbidity of transfusion-associated non-A, non-B (NANB) and type C hepatitis: an NHLBI multi-center study [Abstract]. Hepatology 1994; 20: 204A.
  • 27
    De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994; 20: 12251230.
  • 28
    Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 13341340.
  • 29
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825832.
  • 30
    Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463472.
  • 31
    Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369373.
  • 32
    Gretch D, Corey I, Wilson J, dela Rosa C, Willson R, Carithers RJ, Busch M, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-liter viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 12191225.
  • 33
    Kato N, Yokosuka O, Hosoda K, Ito Y, Ohio M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 1620.
  • 34
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander J, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 18991905.
  • 35
    Dusheiko G, Weiss HS, Brown D, McOmish F, Yap PL, Sherlock S, McLntyre N, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 1318.
  • 36
    Ichimura H, Tamura I, Kurimura O, Koda T, Mizuki M, Tsuchie H, Kurimura T. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J Med Virol 1994; 43: 212215.
  • 37
    Pozzatto G, Morretti M, Franzin F, Croce LS, Tribelli C, Masayu T, Kaneko S, et al. Severity of liver disease with different hepatitis C viral clones [Letter]. Lancet 1991; 338: 509.
  • 38
    Tanaka E, Kiyosawa K, Matsushima T, Ishikawa K, Hino K, Tanaka S, Nose H, et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis. J Gastroenterol Hepatol 1995; 10: 538545.
  • 39
    Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695699.
  • 40
    Romeo R, Tommasini MA, Rumi MG, Sangiovanni A, Fasani P, De Fazio C, Del Ninno E, et al. Genotypes in the progression of hepatitis C related cirrhosis and development of hepatocellular carcinoma [Abstract]. Hepatology 1996; 24: 153A.
  • 41
    Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C quasispecies and progression of liver disease. Hepatology 1994; 20: 11441151.
  • 42
    Farci P, Melpolder JC, Shimoda A, Peddis G, Strazzera A, Munoz S, Purcell RH, et al. Studies of HCV quasispecies in patients with acute resolving hepatitis compared to those who progress to chronic hepatitis [Abstract]. Hepatology 1996; 24: 350A.
  • 43
    Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 6467.
  • 44
    Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osaga T, Aikawa T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996; 91: 119203.
  • 45
    Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cec-chetto A, Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis; a prospective study. Cancer 1994; 27: 24422448.
  • 46
    Pontisso P, Ruvoletto MG, Fattovich G, Nicoletti M, De Moliner L, Chemello L, Noventa F, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 15291533.
  • 47
    Tanaka E, Alter HJ, Nakatsuji Y, Shih JWK, Kim JP, Matsumoto A, Kobayashi M, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740743.
  • 48
    Pawlotsky JM, Roudot-Thoraval F, Pellerin M, Germanidis G, Desai S, Muerhoff AS, Bastie A, et al. GBV-C infection in HCV-infected patients: epidemiological characteristics, influence on HCV infection and response to interferon alfa therapy [Abstract]. Hepatology 1996; 24: 226A.
  • 49
    Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczyn-ski K, Kim JP, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 363: 741746.
  • 50
    Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Weelay R, Shih JW, Kim JP. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747754.
  • 51
    Oshita M, Mita E, Lio K, Ueda K, Ishida H, Sasaki Y, Kasahara A, et al. Hepatitis G virus infection in patients with chronic hepatitis C [Abstract]. Hepatology 1996; 24: 227A.
  • 52
    Nakatsuji Y, Shih JWK, Kobayashi M, Tanaka E, Kiyosawa K, Kim JP, Alter HJ. Hepatitis G virus (HGV) infection in Japanese patients with hepatitis C virus (HCV) [Abstract]. Hepatology 1996; 24: 227A.
  • 53
    Tzouno A, Trichopoulos D, Kaklamani E, Kakhlani E, Zavitsanas X, Koukmantaki Y, Hsieh CL. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer 1991; 49: 377380.
  • 54
    Mendenhall CL, Seeff LB, Diehl AM, Chosn SJ, French SW, Gartside PS, Rossiter PD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14: 581589.
  • 55
    Coelho-Little ME, Jeffers LJ, Bernstein DE, Goodman JS, Reddy KR, De Medina M, Li X, et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995; 19: 11731176.
  • 56
    Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Kata-yama K, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20: 11151120.
  • 57
    Sawada M, Takada A, Takase S, Takada N. Effects of alcohol on the replication of hepatitis C virus. Alcohol 1993; (Suppl 1B): 8590.
  • 58
    Jenkins PJ, Cromie SL, Roberts SK, Finch CF, Dudley FJ. Chronic hepatitis C, alcohol and hepatic fibrosis [Abstract]. Hepatology 1996; 24: 153A.
  • 59
    Noda K, Yoshihara H, Suzuki K, Yamada Y, Kasahara A, Hayashi N, Fusamoto H, et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma-its relationship to alcohol drinking and the age of transfusion. Alcohol Exp Res 1996; 20 (suppl): 95100 A.
  • 60
    Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol 1995; 30: 11131118.
  • 61
    Matsuda Y, Amuro Y, Higashino K, Hada T, Yamamoto T, Fujikura M, Yamaguchi K, et al. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis. Hepatogastroent-erol 1995; 42: 151154.
  • 62
    Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS. Hepatitis C virus antibody in alcoholic patients: association with the presence of portal and/or lobular hepatitis. Arch Intern Med 1993; 153: 965960.
  • 63
    Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15: 101109.
  • 64
    Miyakawa H, Izumi N, Marumo F, Sato C. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis [Abstract]. Alcohol Clin Exp Res 1996; 20 (suppl): 91A.
  • 65
    Mendenhall CL, Moritz T, Chedid A, Polito AJ, Quan S, Rouster S, Roselle G. Relevance of anti-HCV reactivity in patients with alcoholic hepatitis: VA cooperative study group #275. Gastroenterol Jpn 1993; 28 (suppl 5): 95100.